ArticleBritish journal of cancer2012

KRAS mutation detection by high-resolution melting analysis significantly predicts clinical benefit of cetuximab in metastatic colorectal cancer.

U Malapelle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.